
Iron testing can guide care for restless legs, but the diagnosis begins with the symptom pattern.
An uncomfortable urge to move your legs when you sit down in the evening can be more than a nuisance. If movement briefly helps but the sensation returns at rest and repeatedly interrupts sleep, restless legs syndrome may be one possibility.
Ferritin and transferrin saturation (TSAT) are useful in the evaluation of clinically significant restless legs syndrome. They help clinicians consider iron treatment, but neither test can diagnose the condition. The iron thresholds used in restless-legs care also differ from ordinary anemia thresholds.
The International Restless Legs Syndrome Study Group's diagnostic criteria describe a recognizable combination:
People describe the sensations differently: crawling, pulling, tingling, or a deep discomfort that is difficult to name. The relationship to rest, movement, and time of day is often more useful than the precise adjective.
Tell your clinician how often symptoms occur, whether they delay sleep or wake you, and whether they affect travel, evening activities, or daytime functioning. A brief symptom diary can make the pattern easier to assess.

A painful muscle cramp, persistent nerve-related burning or numbness, positional discomfort, and generalized medication-related restlessness can resemble parts of the syndrome. They do not necessarily follow the same pattern. The NHS overview notes that leg cramps and peripheral neuropathy can cause similar symptoms.
A blood result cannot resolve these differences by itself. Someone can have low iron and a separate cause of leg discomfort. Someone else can have restless legs without conventional iron-deficiency anemia.
New one-sided swelling, warmth, redness, or significant leg pain should not be assumed to be restless legs. Seek prompt medical assessment, and emergency care if it occurs with chest pain or trouble breathing.
| Test | What it measures or contributes | What it cannot establish |
|---|---|---|
| Ferritin | Helps assess the body's stored iron. | It is not a direct measurement of brain iron, and inflammation can increase it. |
| Iron and Total Iron Binding Capacity | Measures circulating iron and binding capacity and reports calculated transferrin saturation. | A single result does not diagnose restless legs or determine treatment in isolation. |
| Complete Blood Count with Differential and Platelets | Identifies anemia and other blood-cell findings that may need evaluation. | A normal blood count does not rule out restless legs or low iron stores. |
| C-Reactive Protein (CRP) | May add context when inflammation could be distorting the iron pattern. | It is not an RLS test or a routine requirement for every person with restless legs. |
The Ferritin, Iron and Total Iron Binding Capacity Panel combines the iron measurements in the first two rows. The blood count is separate. Product names and components matter: a test that measures only circulating iron does not answer the same questions as this combined assessment.

A laboratory reference interval, an anemia definition, and a threshold used to consider treatment for a specific disorder are different tools. A result marked “normal” on a laboratory report can still be relevant to a sleep specialist's treatment discussion.
The 2025 American Academy of Sleep Medicine guideline summarizes the following adult iron-treatment considerations. The guideline explicitly describes these thresholds as consensus recommendations that have not been empirically tested.
| Iron finding | How it informs the discussion |
|---|---|
| Ferritin at or below 75 ng/mL, or TSAT below 20% | The statement supports considering iron supplementation, with route selected clinically. |
| Ferritin in the 75–100 ng/mL range | The statement specifies intravenous rather than oral iron when iron treatment is indicated. |
These values are not diagnostic criteria for anemia, universal targets, or instructions to self-treat. An elevated storage result with low saturation requires assessment rather than automatic supplementation. A result at a boundary needs interpretation with the other measurements and clinical circumstances. Children, pregnancy, and advanced kidney disease require separate considerations.
Ask for instructions before the appointment. The AASM favors morning collection and avoiding iron-containing supplements and foods for the preceding 24 hours. Confirm how to apply that guidance to your prescribed treatment and meals with the ordering clinician. Ulta's Iron and Total Iron Binding Capacity test also lists morning fasting collection instructions; follow the instructions agreed with the clinician and collection laboratory.
Record recent iron treatment, including infusions, and any illness around the draw. Do not stop essential medications independently. Consistent preparation helps make serial results more comparable.
The clinician considers both treatment and the reason for the low result. Menstrual loss, blood donation, low intake, and impaired absorption may be relevant. Identifying a contributor helps prevent repeated depletion.
Iron replacement may be part of care, but it is not a promise that every symptom will disappear. Route, duration, follow-up testing, and precautions should be specified. Increasing the dose indefinitely in pursuit of a number can cause harm.
If an oral product causes side effects or results do not respond as expected, report that rather than escalating the dose yourself. If intravenous treatment is considered, the clinician should explain why it fits the overall pattern and how response and adverse effects will be monitored.
The evaluation should return to the clinical pattern. Review sleep habits, other sleep disorders, medical conditions, and the medication list. Some medicines may aggravate symptoms, but the decision to change them belongs with the prescriber.
Regular sleep timing, appropriate daytime activity, and brief movement or stretching during symptoms can be useful parts of a plan. Persistent sleep disruption warrants care even if laboratory results fall within the printed reference intervals. A sleep specialist or neurologist may help when symptoms are difficult to classify or treat.
Follow-up should track the person as well as the laboratory results. Record nights affected, time needed to fall asleep, symptom severity, daytime effects, and treatment side effects. Repeat iron testing should occur on the clinician's schedule and account for the route and timing of replacement.
No. Low reserves deserve attention, but diagnosis still requires the characteristic symptoms and assessment for other explanations.
Yes. The condition is not defined by anemia. A normal blood count therefore does not end the sleep-related assessment.
For a fuller explanation of the measurements, see the iron-studies explainer. The iron-deficiency anemia guide and CBC and Anemia pillar cover the separate questions of iron deficiency and anemia.
| Category | Linked test or panel | Role in this article |
|---|---|---|
| Iron stores and availability | Ferritin Test Iron and Total Iron Binding Capacity Test |
Used together to support a clinical treatment discussion; neither establishes the syndrome. |
| Combined iron panel | Ferritin, Iron and Total Iron Binding Capacity Panel | An alternative grouping of the two iron measurements. |
| Coexisting anemia assessment | Complete Blood Count with Differential and Platelets (CBC) | Assesses anemia; a normal blood count does not exclude restless legs syndrome. |
| Inflammation context — conditional | C-Reactive Protein (CRP) Test | May help when inflammation complicates the iron results; not a routine diagnostic test for restless legs. |
The Complete Blood Count with Differential and Platelets (CBC) includes hemoglobin and red-cell indices. The Iron and Total Iron Binding Capacity Test includes iron, binding capacity, and calculated transferrin saturation. The Ferritin, Iron and Total Iron Binding Capacity Panel groups the storage and transport measurements; it does not include the blood count. Avoid duplicating the panel’s components when selecting tests.

Ulta Lab Tests, LLC.
9237 E Via de Ventura, Suite 220
Scottsdale, AZ 85258
480-681-4081
(Toll Free: 800-714-0424)